ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001758363

Turtle Cameron

CIK 0001758363 Name as filed on the most recent filing

Filed as Turtle Cameron (34)

77 transaction lines · from 34 filings · filed 2019-06-06 to 2026-08-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

77 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-08-03 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 7,157 disposed 95.10 680,630.70 Form 4, filing 0001636282-26-000099
2026-08-03 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 5,635 disposed 95.93 540,565.55 Form 4, filing 0001636282-26-000099
2026-08-03 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 1,392 disposed 96.82 134,773.44 Form 4, filing 0001636282-26-000099
2026-08-03 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 800 disposed 93.97 75,176.00 Form 4, filing 0001636282-26-000099
2026-08-03 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 16 disposed 97.46 1,559.36 Form 4, filing 0001636282-26-000099
2026-07-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 10,176 disposed 87.44 889,789.44 Form 4, filing 0001636282-26-000086
2026-07-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 4,234 disposed 88.12 373,100.08 Form 4, filing 0001636282-26-000086
2026-07-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 590 disposed 88.91 52,456.90 Form 4, filing 0001636282-26-000086
2026-06-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 8,149 disposed 70.50 574,504.50 Form 4, filing 0001636282-26-000077
2026-06-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 3,557 disposed 69.40 246,855.80 Form 4, filing 0001636282-26-000077
2026-06-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 3,294 disposed 71.38 235,125.72 Form 4, filing 0001636282-26-000077
2026-05-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 5,300 disposed 69.54 368,562.00 Form 4, filing 0001758363-26-000009
2026-05-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 3,600 disposed 70.77 254,772.00 Form 4, filing 0001758363-26-000009
2026-05-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 3,100 disposed 73.14 226,734.00 Form 4, filing 0001758363-26-000009
2026-05-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 1,700 disposed 74.23 126,191.00 Form 4, filing 0001758363-26-000009
2026-05-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 1,000 disposed 71.76 71,760.00 Form 4, filing 0001758363-26-000009
2026-05-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 300 disposed 74.96 22,488.00 Form 4, filing 0001758363-26-000009
2026-04-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 12,344 disposed 49.20 607,324.80 Form 4, filing 0001758363-26-000007
2026-04-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 2,656 disposed 49.92 132,587.52 Form 4, filing 0001758363-26-000007
2026-03-02 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 9,100 disposed 42.49 386,659.00 Form 4, filing 0001636282-26-000026
2026-03-02 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 5,900 disposed 41.73 246,207.00 Form 4, filing 0001636282-26-000026
2026-02-02 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 14,043 disposed 32.87 461,593.41 Form 4, filing 0001758363-26-000005
2026-02-02 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 957 disposed 31.82 30,451.74 Form 4, filing 0001758363-26-000005
2026-01-02 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 12,709 disposed 30.47 387,243.23 Form 4, filing 0001758363-26-000002
2026-01-02 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 2,191 disposed 31.79 69,651.89 Form 4, filing 0001758363-26-000002
2026-01-02 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 100 disposed 32.39 3,239.00 Form 4, filing 0001758363-26-000002
2025-12-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 10,995 disposed 28.73 315,886.35 Form 4, filing 0001758363-25-000003
2025-12-01 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 4,005 disposed 29.83 119,469.15 Form 4, filing 0001758363-25-000003
2025-11-03 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 28,155 disposed 23.13 651,225.15 Form 4, filing 0001636282-25-000106
2025-11-03 Spyre Therapeutics, Inc.
SYRE 		S, Open-market sale 16,845 disposed 23.66 398,552.70 Form 4, filing 0001636282-25-000106
2020-12-28 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 10,937 disposed 69.34 758,328.93 Form 4, filing 0000899243-20-035444
2020-12-28 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 8,563 disposed 69.94 598,855.12 Form 4, filing 0000899243-20-035444
2020-12-15 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 11,445 disposed 112.19 1,284,017.98 Form 4, filing 0000899243-20-034181
2020-12-15 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 7,600 disposed 111.31 845,937.00 Form 4, filing 0000899243-20-034181
2020-12-15 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 3,756 disposed 110.29 414,251.49 Form 4, filing 0000899243-20-034181
2020-12-15 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 3,493 disposed 112.97 394,589.19 Form 4, filing 0000899243-20-034181
2020-11-25 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 742 disposed 47.23 35,043.77 Form 4, filing 0000899243-20-032234
2020-11-24 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 4,258 disposed 47.00 200,137.07 Form 4, filing 0000899243-20-032234
2020-11-11 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 9,497 disposed 74.75 709,859.91 Form 4, filing 0000899243-20-031006
2020-11-11 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 3,005 disposed 73.56 221,059.82 Form 4, filing 0000899243-20-031006
2020-11-11 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 908 disposed 75.23 68,307.57 Form 4, filing 0000899243-20-031006
2020-11-05 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 2,500 disposed 42.05 105,124.75 Form 4, filing 0000899243-20-030623
2020-11-02 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 9,145 disposed 70.44 644,208.55 Form 4, filing 0000899243-20-030216
2020-11-02 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 3,146 disposed 71.42 224,676.94 Form 4, filing 0000899243-20-030216
2020-11-02 Eidos Therapeutics, Inc.
EIDX 		S, Open-market sale 209 disposed 72.10 15,068.08 Form 4, filing 0000899243-20-030216
2020-09-30 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 12,442 disposed 37.59 467,750.77 Form 4, filing 0000899243-20-026978
2020-09-30 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 2,058 disposed 38.24 78,706.98 Form 4, filing 0000899243-20-026978
2020-09-18 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 2,500 disposed 42.01 105,024.25 Form 4, filing 0000899243-20-025962
2020-09-15 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 2,500 disposed 37.06 92,651.75 Form 4, filing 0000899243-20-025366
2020-09-11 BridgeBio Pharma, Inc.
BBIO 		S, Open-market sale 2,000 disposed 35.02 70,047.00 Form 4, filing 0000899243-20-025095

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 77
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Turtle Cameron, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001758363

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.